Computationally Guided Intracerebral Drug Delivery via Chronically Implanted Microdevices.

Treatments for neurologic diseases are often limited in efficacy due to poor spatial and temporal control over their delivery. Intracerebral delivery partially overcomes this by directly infusing therapeutics to the brain. Brain structures, however, are nonuniform and irregularly shaped, precluding complete target coverage by a single bolus without significant off-target effects and possible toxicity. Nearly complete coverage is crucial for effective modulation of these structures. We present a framework with computational mapping algorithms for neural drug delivery (COMMAND) to guide multi-bolus targeting of brain structures that maximizes coverage and minimizes off-target leakage. Custom-fabricated chronic neural implants leverage rational fluidic design to achieve multi-bolus delivery in rodents through a single infusion of radioactive tracer (Cu-64). The resulting spatial distributions replicate computed spatial coverage with 5% error in vivo, as detected by positron emission tomography. COMMAND potentially enables accurate, efficacious targeting of discrete brain regions.

[1]  Tomasz Blasiak,et al.  A new approach to detection of the bregma point on the rat skull , 2010, Journal of Neuroscience Methods.

[2]  Xianghui Yu,et al.  Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity , 2017, International journal of medical sciences.

[3]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[4]  C. Vite,et al.  Effective gene therapy for an inherited CNS disease in a large animal model , 2005, Annals of neurology.

[5]  Khalil B. Ramadi,et al.  Characterization of Mechanically Matched Hydrogel Coatings to Improve the Biocompatibility of Neural Implants , 2017, Scientific Reports.

[6]  Yi Ai,et al.  Point source concentration of GDNF may explain failure of phase II clinical trial , 2006, Experimental Neurology.

[7]  A. Lozano,et al.  Directional deep brain stimulation: an intraoperative double-blind pilot study. , 2014, Brain : a journal of neurology.

[8]  Pavel Osten,et al.  Stereotaxic gene delivery in the rodent brain , 2007, Nature Protocols.

[9]  S. Gambhir,et al.  Positron emission tomography reporter gene strategy for use in the central nervous system , 2019, Proceedings of the National Academy of Sciences.

[10]  Robert Langer,et al.  Miniaturized neural system for chronic, local intracerebral drug delivery , 2018, Science Translational Medicine.

[11]  Roger J. McNichols,et al.  MR-guided stereotactic laser ablation of epileptogenic foci in children , 2012, Epilepsy & Behavior.

[12]  Anatol C. Kreitzer,et al.  Thermal constraints on in vivo optogenetic manipulations , 2019, Nature Neuroscience.

[13]  Nizan Meitav,et al.  Realistic Numerical and Analytical Modeling of Light Scattering in Brain Tissue for Optogenetic Applications123 , 2016, eNeuro.

[14]  Bruce S. McEwen,et al.  Stress, memory and the amygdala , 2009, Nature Reviews Neuroscience.

[15]  F. Maes,et al.  Image-based in vivo assessment of targeting accuracy of stereotactic brain surgery in experimental rodent models , 2016, Scientific Reports.

[16]  Seth Love,et al.  Convection‐Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations , 2014, Brain pathology.

[17]  Sachie K. Ogawa,et al.  Whole-Brain Mapping of Direct Inputs to Midbrain Dopamine Neurons , 2012, Neuron.

[18]  S. Blinder,et al.  Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease , 2019, Journal of Parkinson's disease.

[19]  Audrey Lee-Gosselin,et al.  Acoustically targeted chemogenetics for the non-invasive control of neural circuits , 2018, Nature Biomedical Engineering.

[20]  Ken-ichi Amemori,et al.  Localized Microstimulation of Primate Pregenual Cingulate Cortex Induces Negative Decision-Making , 2012, Nature Neuroscience.

[21]  G. Chadi,et al.  Striatal injection of 6-hydroxydopamine induces retrograde degeneration and glial activation in the nigrostriatal pathway , 2003 .

[22]  H. Soreq,et al.  Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome. , 2013, Journal of visualized experiments : JoVE.

[23]  Z. Qin,et al.  Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. , 1999, Molecular pharmacology.

[24]  Xianghui Yu,et al.  Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression , 2017, PloS one.

[25]  Aaron Fenster,et al.  Integration and evaluation of a needle-positioning robot with volumetric microcomputed tomography image guidance for small animal stereotactic interventions. , 2010, Medical physics.

[26]  A. Shaywitz,et al.  Best practices for the use of intracerebroventricular drug delivery devices. , 2018, Molecular genetics and metabolism.

[27]  R. Crystal,et al.  Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial , 2017, The Lancet Neurology.

[28]  C. Shults,et al.  Intrastriatal injection of GDNF attenuates the effects of 6‐hydroxydopamine , 1996, Neuroreport.

[29]  Hangyi Jiang,et al.  AtlasGuide: Software for stereotaxic guidance using 3D CT/MRI hybrid atlases of developing mouse brains , 2013, Journal of Neuroscience Methods.

[30]  R. Thorne,et al.  Diffusion of macromolecules in the brain: implications for drug delivery. , 2013, Molecular pharmaceutics.

[31]  M. Perricaudet,et al.  Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease , 1994, Neuroreport.

[32]  S. Gill,et al.  Convection-enhanced delivery of MANF — Volume of distribution analysis in porcine putamen and substantia nigra , 2015, Journal of the Neurological Sciences.

[33]  C. Marsden,et al.  Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70 , 1988, FEBS letters.

[34]  D. Schoepp,et al.  Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[35]  A Schweikard,et al.  A robotic assistant for stereotactic neurosurgery on small animals , 2008, The international journal of medical robotics + computer assisted surgery : MRCAS.

[36]  Patrícia A. Correia,et al.  Stereotaxic Adeno-associated Virus Injection and Cannula Implantation in the Dorsal Raphe Nucleus of Mice , 2017, Bio-protocol.

[37]  G. Roth,et al.  Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats , 1998, Neuroreport.

[38]  N. Garcia-Cairasco,et al.  A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications , 2018, Front. Behav. Neurosci..

[39]  J. Dostrovsky,et al.  Pathological basal ganglia activity in movement disorders , 2011, Neuroscience.

[40]  J. Coyle,et al.  Local and distant neuronal degeneration following intrastriatal injection of kainic acid. , 1980, Journal of neuropathology and experimental neurology.

[41]  W. Banks,et al.  From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.

[42]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[43]  Bryan Kolb,et al.  The variability of the interaural line vs the stability of bregma in rat stereotaxic surgery , 1977, Physiology & Behavior.

[44]  Raghu Raghavan,et al.  Poor drug distribution as a possible explanation for the results of the PRECISE trial. , 2010, Journal of neurosurgery.

[45]  J. Wolfe,et al.  A Single Injection of an Adeno-Associated Virus Vector into Nuclei with Divergent Connections Results in Widespread Vector Distribution in the Brain and Global Correction of a Neurogenetic Disease , 2007, The Journal of Neuroscience.

[46]  C. Lind,et al.  Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease , 2011, Journal of Clinical Neuroscience.

[47]  G. Allan Johnson,et al.  A quantitative magnetic resonance histology atlas of postnatal rat brain development with regional estimates of growth and variability , 2013, NeuroImage.

[48]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[49]  Khalil B. Ramadi,et al.  Focal, remote-controlled, chronic chemical modulation of brain microstructures , 2018, Proceedings of the National Academy of Sciences.

[50]  P. Sørensen,et al.  Intracranial pressure and cerebrospinal fluid outflow conductance in healthy subjects. , 1991, Journal of neurosurgery.

[51]  K. Frey,et al.  Intrastriatal Neurotoxin Injections Reduce in Vitro and in Vivo Binding of Radiolabeled Rotenoids to Mitochondrial Complex I , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  J. Jankovic,et al.  Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD , 2003, Neurology.

[53]  Robert Langer,et al.  Steerable Microinvasive Probes for Localized Drug Delivery to Deep Tissue. , 2019, Small.

[54]  S. Leff,et al.  Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease , 1998, The Journal of Neuroscience.

[55]  D. Kirik,et al.  Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  Jonathan Richard Shewchuk,et al.  Delaunay refinement algorithms for triangular mesh generation , 2002, Comput. Geom..

[57]  S. Cragg,et al.  Dopamine release in the basal ganglia , 2011, Neuroscience.

[58]  S. Larson,et al.  Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. , 2018, The Lancet. Oncology.

[59]  J. Mallet,et al.  Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  I. Date,et al.  The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages , 2000, Neuroscience Research.

[61]  A. Björklund,et al.  Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal System , 2000, The Journal of Neuroscience.

[62]  Thomas Wichmann,et al.  Circuits and circuit disorders of the basal ganglia. , 2007, Archives of neurology.

[63]  Marc V. Fuccillo,et al.  Striatal Circuits as a Common Node for Autism Pathophysiology , 2016, Front. Neurosci..